paclitaxel has been researched along with Dermatitis Medicamentosa in 64 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (26.56) | 18.2507 |
| 2000's | 26 (40.63) | 29.6817 |
| 2010's | 18 (28.13) | 24.3611 |
| 2020's | 3 (4.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, B; Kamiya, K; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M; Sashikawa, M | 1 |
| Hinds, B; Marsch, AF; Shakhbazova, A | 1 |
| Alamón-Reig, F; Fuertes de Vega, I; Laguna, JC; Rizo-Potau, D | 1 |
| Chao, GY; Depenbrock, H; Khalil, M; Kim, JH; Luft, A; Mayo, C; Natale, R; Obasaju, C; Ramlau, R; Spigel, DR | 1 |
| Blaydorn, L; Coats, J; Farley, JH; Khemka, V; Lynch, CA; McGahey, K; Niu, J; Sangal, A; Waypa, J; Weiss, GJ | 1 |
| Espinosa Lara, P; Jiménez-Reyes, J; Medina-Puente, C; Riquelme Oliveira, A | 1 |
| Banner, R; Kahan, J | 1 |
| De Haes, P; Morren, MA; Noë, E; Van Cutsem, E; Van den Oord, JJ; Verhulst, L; Verslype, C | 1 |
| Bai, LY; Chen, CY; Chiu, CF | 1 |
| Agbor-Tarh, D; Aktas, B; Azim, HA; Baselga, J; Bradbury, I; de Azambuja, E; Di Cosimo, S; Dinh, P; Dreosti, L; Eidtmann, H; Greger, JG; Hsieh, RK; Huang, CS; Jackisch, C; Kim, SB; Piccart, M; Smith, I; Vuylsteke, P | 1 |
| Chambers, CJ; Liu, H; Sharon, VR; White, CR; White, KP | 1 |
| Akcakanat, A; Chen, H; Culotta, KS; Do, KA; Doyle, LA; Gonzalez-Angulo, AM; Krop, I; Kurzrock, R; Li, Y; Liu, S; Meric-Bernstam, F; Mills, GB; Moulder-Thompson, S; Piha-Paul, S; Sahin, AA; Tarco, E; Velez-Bravo, V; Winer, EP | 1 |
| Fujii, M; Honma, M; Ishida-Yamamoto, A; Takahashi, I | 1 |
| Boulinguez, S; Gadaud, N; Gladieff, L; Guenounou, S; Lamant, L; Masson Regnault, M; Recher, C; Roche, H; Sibaud, V; Tournier, E | 1 |
| Fujiwara, Y; Giranda, V; Hashiba, H; Horinouchi, H; Kanda, S; Kitazono, S; Mizugaki, H; Nokihara, H; Qian, J; Shepherd, SP; Tamura, T; Xiong, H; Yagishita, S; Yamamoto, N | 1 |
| Dang, C; Friedman, MD; Lacouture, M | 1 |
| Hazan, E; Sahu, J; Santa, E | 2 |
| Belum, VR; Dalenc, F; Deslandres, M; Eche, A; Gladieff, L; Lacouture, ME; Lebœuf, NR; Montastruc, M; Roche, H; Sibaud, V; Vigarios, E | 1 |
| González-Serva, A; Konnikov, N; Seidler, AM; Wasserman, DI | 1 |
| Bosnjak, SM; Radulovic, S; Susnjar, S | 1 |
| Egoshi, K; Fukasawa, S; Hamano, M; Ichikawa, T; Imamura, Y; Maruoka, M; Miyasaka, K; Nakamura, K; Nihei, N; Sazuka, T; Suyama, T; Ueda, T | 1 |
| Cruz, A; Hines-Telang, G; Kroumpouzos, G; Temu, T | 1 |
| Kanekura, T; Kawai, K; Tamai, M | 1 |
| Chiu, HC; Chu, CY; Yang, CH | 1 |
| Fehr, M; Hafner, J; Läuchli, S; Trüeb, RM | 1 |
| Bagaméri, A; Lehoczky, O; Pulay, T | 1 |
| Eich, D; Eich, HT; Krieg, T; Scharffetter-Kochanek, K; Tantcheva-Poor, I | 1 |
| Remlinger, KA | 1 |
| Balguerie, X; Chinet, P; Courville, P; Joly, P; Kupfer, I | 1 |
| Hardwicke, F; Stanford, BL | 1 |
| Chang, TW; Chen, GY; Chen, WC | 1 |
| Sakashita, A; Sato, A; Taguchi, S | 1 |
| Farrant, PB; Gore, M; Mortimer, PS | 1 |
| Abdel-Wahab, M; Abitbol, A; Hamilton, K; Lewin, A; Markoe, A; Troner, M | 1 |
| Eisenbeilss, C; Weizel, J; Wolff, H | 1 |
| Berghmans, T; Klastersky, J | 1 |
| Baux, S; Canuel, C; Cartier, S; de Gramont, A; Debray, M; Demuynck, B; Louvet, C; Mimoun, M; Raymond, E; Varette, C | 1 |
| Burris, HA; Cook, G; Irvin, R; Keeling, JH; Kuhn, J; McCollough, ML; Von Hoff, DD; Zimmerman, GC | 1 |
| Meehan, JL; Sporn, JR | 1 |
| Abbruzzese, JL; Ajani, JA; Bready, B; Lassere, Y; Levin, B; Patt, Y; Pazdur, R; Soh, LT; Soo, E; Sugarman, S | 1 |
| Alakl, M; Clavel, M; Franklin, H; Piccart, M; Prove, AM; Steward, W; ten Bokkel Huinink, WW; Tursz, T; Verweij, J; Wanders, J | 1 |
| Buzdar, A; Cohen, PR; Dhingra, K; Gagel, R; Holmes, F; Payne, JY | 1 |
| James, WD; Lee, N; Montemarano, AD; Sau, P; Weiss, RB; Young, PC | 1 |
| Barnicle, M; Blendowski, C; Goodman, M; Lydon, J; Petersen, J; Stewart, I; Wickham, R | 1 |
| Trudeau, ME | 1 |
| Akerley, W | 1 |
| Egan, CL; Guzzo, CA; Laughinghouse, KA; Li, LJ; Tangoren, IA; Weinberg, JM | 1 |
| Johnson, PJ; Leung, SF; Yeo, W | 1 |
| Awada, A; Bontenbal, M; Coleman, R; Klijn, J; Mauriac, L; Nooij, M; Paridaens, R; Piccart, MJ; Selleslags, J; Van Glabbeke, M; Van Vreckem, A | 1 |
| Arlet, P; Auvinet, M; Dahan, S; Dingremont, C; Juchet, H; Ollier, S | 1 |
| Balis, FM; Blaney, SM; Hutchinson, R; Krailo, M; Mosher, RB; O'Brien, M; Reaman, GH; Seibel, NL | 1 |
| Ajaikumar, BS; Cleveland, MG; Reganti, R | 1 |
| Aviles, V; Chalian, AA; Kligerman, MM; Machtay, M; Mirza, N; Rosenthal, DI; Treat, J; Weber, RS; Weinstein, GS | 1 |
| Chiu, HC; Chu, CY; Hsiao, GH; Yang, CH; Yang, CY | 1 |
| Ayhan, A; Baykal, C; Erkek, E; Tutar, E; Yüce, K | 1 |
| de la Brassinne, M; Richert, B; Vandenbossche, L; Vandeveire, A; Vanhooteghem, O; Vindevoghel, A | 1 |
| Aletti, G; Beatrice, S; Carnelli, M; Ferrari, A; Frigerio, L; Garavaglia, E; Mangili, G | 1 |
| Inbar, MJ; Merimsky, O | 1 |
| Giesel, BU; Kutz, GG; Thiel, HJ | 1 |
| Hirai, K; Ishii, M; Ishiko, O; Kanaoka, Y; Nakajima, S; Nakamura, Y; Ogita, S; Oiso, N | 1 |
| Doval, DC; Pavithran, K | 1 |
| Alexopoulou, A; Deutsch, M; Dourakis, SP; Sevastianos, VA; Stavrianeas, N | 1 |
12 review(s) available for paclitaxel and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Eruptions; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Scleroderma, Localized | 2018 |
Eruptive purpuric papules on the arms; a case of chemotherapy-induced inflammation of actinic keratoses and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Eruptions; Epidermis; Forearm; Hepatitis B, Chronic; Humans; Keratosis, Actinic; Lung Neoplasms; Male; Necrosis; Paclitaxel; Purpura; Sunlight; Vasculitis | 2014 |
Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Eruptions; Female; Humans; Hyperpigmentation; Idarubicin; Lomustine; Male; Middle Aged; Paclitaxel; Vincristine | 2015 |
Dermatological adverse events with taxane chemotherapy.
Topics: Alopecia; Antineoplastic Agents; Docetaxel; Drug Eruptions; Edema; Humans; Lupus Erythematosus, Cutaneous; Nail Diseases; Paclitaxel; Pigmentation Disorders; Radiodermatitis; Taxoids | 2016 |
Cutaneous reactions to chemotherapy drugs: the art of consultation.
Topics: Animals; Antineoplastic Agents; Bleomycin; Docetaxel; Doxorubicin; Drug Eruptions; Humans; Hydroxyurea; Paclitaxel; Skin; Taxoids; Thalidomide | 2003 |
A review of clinical experience with paclitaxel extravasations.
Topics: Antineoplastic Agents, Phytogenic; Drug Eruptions; Extravasation of Diagnostic and Therapeutic Materials; Humans; Injections, Intravenous; Paclitaxel; Quality Assurance, Health Care | 2003 |
Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Drug Eruptions; Exudates and Transudates; Female; Fluorouracil; Humans; Middle Aged; Nail Diseases; Paclitaxel; Taxoids | 2003 |
[Hypersensitivity reactions to cancer chemotherapeutic agents].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cisplatin; Drug Eruptions; Drug Hypersensitivity; Fever; Histamine H1 Antagonists; Humans; Lymphoma, Non-Hodgkin; Neoplasms; Paclitaxel; Respiration Disorders; Rituximab; Trastuzumab | 2003 |
Scleroderma and the taxanes. Is there really a link?
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Female; Humans; Middle Aged; Paclitaxel; Scleroderma, Systemic | 2004 |
Docetaxel: a review of its pharmacology and clinical activity.
Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Division; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Eruptions; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Microtubules; Neutropenia; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Taxoids; Tubulin | 1996 |
Generalized pustular dermatosis following paclitaxel therapy.
Topics: Adult; Antineoplastic Agents, Phytogenic; Biopsy, Needle; Breast Neoplasms; Diagnosis, Differential; Drug Eruptions; Female; Humans; Neoplasms; Paclitaxel; Skin Diseases, Vesiculobullous | 1997 |
[Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Drug Eruptions; Female; Humans; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy Dosage; Taxoids | 2001 |
17 trial(s) available for paclitaxel and Dermatitis Medicamentosa
| Article | Year |
|---|---|
An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Eruptions; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Response Evaluation Criteria in Solid Tumors; Survival Rate | 2017 |
A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus).
Topics: Adenocarcinoma; Adult; Aged; Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Diarrhea; Docetaxel; Doxorubicin; Drug Eruptions; Fatigue; Female; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Polyethylene Glycols; Sarcoma; Small Cell Lung Carcinoma; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine; Vomiting | 2017 |
Pattern of rash, diarrhea, and hepatic toxicities secondary to lapatinib and their association with age and response to neoadjuvant therapy: analysis from the NeoALTTO trial.
Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Diarrhea; Drug Administration Schedule; Drug Eruptions; Female; Humans; Incidence; Lapatinib; Logistic Models; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Quinazolines; Receptor, ErbB-2; Time Factors; Trastuzumab | 2013 |
SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Drug Administration Schedule; Drug Eruptions; Fatigue; Female; Heterocyclic Compounds, 3-Ring; Humans; Hyperglycemia; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Severity of Illness Index; Treatment Outcome | 2015 |
A phase 1 study evaluating the pharmacokinetics and preliminary efficacy of veliparib (ABT-888) in combination with carboplatin/paclitaxel in Japanese subjects with non-small cell lung cancer (NSCLC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Benzimidazoles; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Eruptions; Drug Synergism; Female; Hematologic Diseases; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Poly(ADP-ribose) Polymerase Inhibitors; Radiography; Salvage Therapy; Tumor Burden | 2015 |
Dermatologic Adverse Events Associated With Use of Adjuvant Lapatinib in Combination With Paclitaxel and Trastuzumab for HER2-Positive Breast Cancer: A Case Series Analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Eruptions; Female; Humans; Lapatinib; Middle Aged; Paclitaxel; Quinazolines; Trastuzumab | 2016 |
Severe skin toxicity observed with the combination of capecitabine and weekly paclitaxel in metastatic breast cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Female; Fluorouracil; Humans; Neoplasm Metastasis; Paclitaxel; Skin Diseases | 2008 |
Combination of gemcitabine and paclitaxel as second-line chemotherapy for advanced urothelial carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytidine; Drug Eruptions; Female; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Prognosis; Survival Rate; Thrombocytopenia; Urinary Bladder Neoplasms | 2009 |
Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Drug Eruptions; Esophageal Stenosis; Female; Fluorouracil; Follow-Up Studies; Gastrostomy; Head and Neck Neoplasms; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Quality of Life; Radiotherapy, Adjuvant; Surveys and Questionnaires; Survival Rate | 2005 |
Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Docetaxel; Drug Eruptions; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Taxoids | 1995 |
Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Colorectal Neoplasms; Docetaxel; Drug Administration Schedule; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids | 1994 |
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Eruptions; Europe; Female; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Remission Induction; Taxoids | 1994 |
Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer.
Topics: Alopecia; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Drug Eruptions; Drug Tolerance; Humans; Lung Diseases; Lung Neoplasms; Muscular Diseases; Neoplasm Metastasis; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases | 1996 |
Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Body Fluids; Breast Neoplasms; Cetirizine; Docetaxel; Drug Administration Schedule; Drug Eruptions; Edema; Europe; Female; Histamine H1 Antagonists; Humans; Methylprednisolone; Middle Aged; Paclitaxel; Pleural Effusion; Severity of Illness Index; Skin; Taxoids; Treatment Outcome; Water-Electrolyte Imbalance | 1997 |
Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Docetaxel; Dose-Response Relationship, Drug; Drug Eruptions; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infant; Male; Neoplasms; Neutropenia; Paclitaxel; Recombinant Proteins; Taxoids | 1999 |
A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Drug Eruptions; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Radiation-Sensitizing Agents; Stomatitis | 1999 |
Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study.
Topics: Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Diarrhea; Drug Administration Schedule; Drug Eruptions; Endometrial Neoplasms; Feasibility Studies; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Radiation Injuries; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy; Radiotherapy, Adjuvant; Risk Factors | 2001 |
35 other study(ies) available for paclitaxel and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Rare case of acquired perforating dermatosis induced by cetuximab.
Topics: Antineoplastic Agents; Cetuximab; Chemoradiotherapy, Adjuvant; Drug Eruptions; Female; Humans; Middle Aged; Paclitaxel; Tongue Neoplasms; Withholding Treatment | 2020 |
Lichenoid inflammation of DSAP lesions following treatment with durvalumab, olaparib and paclitaxel: A potential diagnostic pitfall mimicking lichenoid drug eruptions associated with PDL-1 inhibitors.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diagnosis, Differential; Drug Eruptions; Female; Humans; Inflammation; Lichenoid Eruptions; Paclitaxel; Phthalazines; Piperazines; Porokeratosis; Skin | 2020 |
Paclitaxel-related eruption mimicking dermatomyositis.
Topics: Dermatomyositis; Drug Eruptions; Exanthema; Humans; Paclitaxel | 2021 |
Eruptive cherry angiomas developing in a patient treated with ramucirumab.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Exanthema; Hemangioma; Humans; Liver Neoplasms; Male; Paclitaxel; Peritoneal Neoplasms; Ramucirumab; Stomach Neoplasms; Withholding Treatment | 2018 |
A localised skin reaction after chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Drug Eruptions; Endometrial Neoplasms; Erythema; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Spinal Neoplasms | 2018 |
Treatment of pembrolizumab-induced cutaneous lesions with ruxolitinib.
Topics: Adenocarcinoma; Aged; Ampulla of Vater; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arm; Common Bile Duct Neoplasms; Drug Eruptions; Glucocorticoids; Histamine Antagonists; Humans; Janus Kinase Inhibitors; Liver Neoplasms; Male; Nitriles; Paclitaxel; Prednisolone; Pyrazoles; Pyrimidines; Scrotum; Thigh; Torso | 2019 |
Toxic erythema with eccrine squamous syringometaplasia induced by nanoparticle albumin-bound paclitaxel.
Topics: Aged; Albumins; Antineoplastic Agents, Phytogenic; Drug Eruptions; Eccrine Glands; Erythema; Humans; Male; Paclitaxel | 2015 |
Diffuse Rash After the Administration of Carboplatin and Paclitaxel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinosarcoma; Drug Eruptions; Eczema; Exanthema; Female; Humans; Middle Aged; Paclitaxel; Skin; Uterine Neoplasms | 2016 |
Diffuse Rash After the Administration of Carboplatin and Paclitaxel: Answer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinosarcoma; Drug Eruptions; Eczema; Exanthema; Female; Humans; Middle Aged; Paclitaxel; Skin; Uterine Neoplasms | 2016 |
Amyopathic dermatomyositis resembling stasis dermatitis.
Topics: Aged, 80 and over; Antineoplastic Agents; Carboplatin; Dermatomyositis; Diagnosis, Differential; Drug Eruptions; Female; Humans; Leg Dermatoses; Ovarian Neoplasms; Paclitaxel; Paraneoplastic Syndromes; Skin; Venous Insufficiency | 2008 |
Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Eruptions; Erythema; Female; Hand Dermatoses; Humans; Leg Dermatoses; Neutrophils; Paclitaxel | 2011 |
Late-onset papular eruption after the initial course of combination chemotherapy consisting of paclitaxel and carboplatin: report of two cases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Eruptions; Female; Humans; Paclitaxel; Time Factors | 2012 |
Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Eruptions; Epirubicin; Erythema; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Paresthesia; Skin; Taxoids | 2002 |
Scleroderma-like drug reaction to paclitaxel (Taxol).
Topics: Aged; Antineoplastic Agents, Phytogenic; Drug Eruptions; Female; Humans; Paclitaxel; Scleroderma, Systemic | 2002 |
[Reinduction of paclitaxel therapy after a successfully treated hypersensitivity reaction].
Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Ovarian Neoplasms; Paclitaxel | 2002 |
Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Docetaxel; Drug Eruptions; Erythema; Female; Foot; Hand; Humans; Infusions, Intravenous; Middle Aged; Paclitaxel; Skin Diseases; Sweat Gland Diseases; Syndrome; Taxoids | 2002 |
Scleroderma-like cutaneous lesions induced by paclitaxel: a case study.
Topics: Antineoplastic Agents, Phytogenic; Drug Eruptions; Erythema; Fatal Outcome; Female; Humans; Middle Aged; Paclitaxel; Scleroderma, Localized | 2003 |
[Scleroderma-like skin changes following administration of paclitaxel for the treatment of ovarian carcinoma].
Topics: Diagnosis, Differential; Drug Eruptions; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Scleroderma, Diffuse; Skin | 2003 |
Paclitaxel-induced cutaneous toxicity.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cellulitis; Drug Eruptions; Erythema; Extravasation of Diagnostic and Therapeutic Materials; Humans; Lung Neoplasms; Lymphangitis; Male; Paclitaxel; Skin | 1995 |
[Extravasation of paclitaxel (Taxol)].
Topics: Aged; Drug Eruptions; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Necrosis; Paclitaxel; Skin | 1995 |
Case report of Taxol administration via central vein producing a recall reaction at a site of prior Taxol extravasation.
Topics: Catheterization, Central Venous; Drug Eruptions; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Infusions, Intravenous; Middle Aged; Paclitaxel; Recurrence | 1994 |
Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.
Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Eruptions; Erythema Multiforme; Female; Humans; Hyperbilirubinemia; Hypercalcemia; Liver Neoplasms; Middle Aged; Mouth Diseases; Neoplasm Proteins; Paclitaxel; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins; Vaginal Diseases | 1996 |
Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Eruptions; Female; Humans; Middle Aged; Paclitaxel; Skin Diseases, Vesiculobullous | 1996 |
Use caution when managing paclitaxel and taxotere infiltrations.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Drug Eruptions; Humans; Infusions, Intravenous; Neoplasms; Nursing Assessment; Paclitaxel; Taxoids | 1996 |
Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold.
Topics: Abdominal Muscles; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Eruptions; Female; Humans; Middle Aged; Paclitaxel; Radiodermatitis; Radiotherapy Dosage; Taxoids | 1997 |
[Yellow nails].
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Eruptions; Female; Hand Dermatoses; Humans; Middle Aged; Nail Diseases; Paclitaxel; Pigmentation Disorders; Taxoids | 1998 |
Cutaneous fibrosis induced by docetaxel: a case report.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Eruptions; Female; Fibrosis; Humans; Paclitaxel; Skin; Taxoids | 2000 |
Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel.
Topics: Adult; Antineoplastic Agents, Phytogenic; Drug Eruptions; Erythema; Female; Humans; Injections, Intravenous; Male; Middle Aged; Paclitaxel; Paresthesia | 2000 |
Cutaneous fixed drug eruption to paclitaxel; a case report.
Topics: Adenocarcinoma; Adrenal Cortex Hormones; Aged; Antineoplastic Agents, Phytogenic; Biopsy, Needle; Chemotherapy, Adjuvant; Drug Eruptions; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Paclitaxel; Treatment Outcome | 2000 |
Subungual abscess: a new ungual side-effect related to docetaxel therapy.
Topics: Abscess; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Eruptions; Female; Humans; Middle Aged; Nail Diseases; Paclitaxel; Taxoids | 2000 |
Herceptin-taxol related hand and foot syndrome.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Eruptions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Paclitaxel; Syndrome; Trastuzumab | 2000 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aged; Amlodipine; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; BCG Vaccine; Cefotetan; Cephamycins; Contrast Media; Cysteine; Dapsone; Diltiazem; Dipyrone; Docetaxel; Drug Eruptions; Echinacea; Enoxaparin; Female; Fructose; Glucans; Glucose; Gold Sodium Thiomalate; Humans; Ibuprofen; Icodextrin; Ioxaglic Acid; Male; Middle Aged; Minocycline; Paclitaxel; Pregnancy; Solvents; Taxoids; Topiramate; Triamcinolone; Trichloroethylene | 2001 |
Local erythematous dermatitis after intravenous docetaxel.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Eruptions; Erythema Multiforme; Female; Firearms; Humans; Infusions, Intravenous; Ovarian Neoplasms; Paclitaxel; Taxoids | 2002 |
Nail changes due to docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Drug Eruptions; Female; Humans; Male; Middle Aged; Nail Diseases; Paclitaxel; Taxoids | 2002 |
Treatment side effects. Case 2. Toxic, epidermal, necrolysis-like reaction associated with docetaxel chemotherapy.
Topics: Adult; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Eruptions; Female; Humans; Lymphoma, Non-Hodgkin; Neutropenia; Paclitaxel; Salvage Therapy; Taxoids; Treatment Outcome | 2002 |